Viewing Study NCT00920257


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-26 @ 12:07 PM
Study NCT ID: NCT00920257
Status: COMPLETED
Last Update Posted: 2017-11-13
First Post: 2009-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module